News | Heart Valve Technology | September 17, 2018

4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018

Early adopters will share attributes, implant procedure experience with transcatheter mitral valve replacement (TMVR) device

4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018

September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve transcatheter mitral valve replacement (TMVR) technology will be highlighted at the Transcatheter Cardiovascular Therapeutics (TCT) meeting, Sept. 21-25, 2018 in San Diego. The technology will be highlighted in the following presentations:

  • Friday, Sept. 21, 2018 at 3:45 p.m. during Innovation Sessions:
    • "4C Medical's AltaValve: The First Human Experience" by Josep Rodés-Cabau, M.D.;
  • Sunday, Sept. 23, 2018 at 3:50 p.m. during Edited Taped Cases:
    • "AltaValve TMVR" presented by Rodés-Cabau; and
  • Monday, Sept. 24, 2018 at 10:12 a.m. during Didactic Session: Transcatheter Mitral Valve Therapies, Part 2 - TMVR:
    • "AltaValve: Device Attributes, Implant Procedure, and First-in-Human" presented by Philippe Généreux, M.D.

Rodés-Cabau is the director of catheterization and interventional laboratories in Quebec Heart and Lung Institute, associate professor of medicine of Laval University and Canadian Research Chair "Fondation Famille Jacques Larivière" for the Development of Structural Heart Disease Interventions (Quebec City, Quebec, Canada).

Généreux is co-director of the Structural Heart Program at the Gagnon Cardiovascular Institute of Morristown Medical Center (Morristown, N.J.) and a practicing Interventional cardiologist at Hôpital du Sacré-Coeur de Montréal (Montreal, Canada).

In contrast with other TMVR devices, the AltaValve is the first mitral regurgitation (MR) treatment device that is placed in the left atrium, thus preserving the left ventricle. Furthermore, due to supra-annular positioning of the valve, AltaValve avoids issues related to the complexity and dynamics of the mitral annulus, making it suitable for patients independent of their MR mechanism.

The AltaValve is a self-expanding device that may be inserted into the left atrium using either a transseptal or a transapical delivery system.

For more information: www.4cmed.com

 

Related Content

News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...